Delivery Order SPE2DB22D1106-SPE2DB25FEYH6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dexamethasone 10 mg/ml vials with a ceiling value of $1,171.69. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is to be completed by September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,488.18 delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Dexamethasone 20 mg/5 ml vials. This competitively awarded, firm fixed-price contract is set to be completed by June 30, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Dexamethasone 20 mg/5 mL vials (5 mL unit size) under a firm fixed-price contract valued at $1,069.60. The award was competitively issued on May 30, 2025, with an ultimate completion date of June 2, 2025, and does not include a set-aside designation. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.52 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract involves the delivery of a corticosteroid medication commonly utilized across military and federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dexamethasone 20 mg/5 ml vials in 5 ml quantities, with a ceiling value of $1,046.46. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dexamethasone 0.5 mg/5 mL elixir in 237 mL quantities, with a ceiling value of $3,838.74. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The pharmaceutical will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Dexamethasone 4 mg tablets (100 count) with a ceiling value of $1,865.16. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, will be performed at the contractor's Conshohocken facility. The award was made without a set-aside designation,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,910.94 for Dexamethasone 0.5 mg/5 ml elixir (237 ml) on September 10, 2025, with completion scheduled for September 11, 2025. The contract utilized firm fixed-price pricing and was not designated as a set-aside award, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYH6Delivery Order
The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,945.52 for Dexamethasone 20 mg/5 mL vials (5 mL quantity) on a firm fixed price basis. This award, issued on July 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for U.S. military and federal healthcare systems globally. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 18, 2025. This delivery order exemplifies the operational execution of the DLA's pharmaceutical prime vendor program, through which AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare operations. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen leverages its SPE2DX indefinite delivery contract to fulfill routine pharmaceutical needs across therapeutic domains. The dexamethasone order—a corticosteroid medication with widespread clinical applications in military medical operations—demonstrates the company's role in ensuring continuous availability of essential medications for Defense Health Agency beneficiaries, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/17/25 |